Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 3 2015

Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Bio-Growth Slowing?
By Eric Langer, BioPlan Associates
Published May 4, 2012
A new report details bio-outsourcing trends in 2012 Read More »
Bio-CMO Industry Trends
By William Downey, HighTech Business Decisions
Published May 4, 2012
Recent initiatives in biopharma contract manufacturing Read More »
Biosimilar Outsourcing Update
By Gil Roth, Contract Pharma
Published May 4, 2012
FDA’s draft guidance leads to new opportunities Read More »
By Gil Roth
Published May 3, 2012
Preclinical revenues drop, offset by RMS uptick Read More »
By Gil Roth
Published May 2, 2012
Offers ultra high-res, MS-Based biomolecular profiling Read More »
By Gil Roth
Published May 2, 2012
Johnson to support oncology, biopharma, device clients Read More »
By Gil Roth
Published May 2, 2012
Scottsdale site to provide diagnostics services Read More »
Published April 24, 2012
Offers advanced bioprotein production Read More »
Published April 12, 2012
Biopharma veteran brings 30 years of experience Read More »
By Michael Martorelli
Published April 4, 2012
. . . and there are ¢¢acquisitions¢¢ Read More »
Packaging Trends and Anti-counterfeiting Initiatives
By Kristin Brooks
Published April 4, 2012
Contract packagers and suppliers see opportunities Read More »
Parenteral Outsourcing Trends
Published April 4, 2012
More opportunities, but greater regulatory scrutiny Read More »
Published March 29, 2012
Will co-promote system to quantify clinical and commercial healthcare decisions Read More »
Published March 22, 2012
New lab suite offers analytical testing, development support and regulatory services Read More »
Published March 21, 2012
Bruno brings 18 years of clinical and regulatory expertise Read More »
By Gil Roth
Published March 7, 2012
Boosts single-use biopharma manufacturing business Read More »
By Wes Wheeler, Marken
Published March 7, 2012
Criteria for selecting a provider Read More »
By Mak Jawadekar, Contributing Editor
Published March 7, 2012
Oncobiologics: a case study Read More »
Industry Adopting More Complex Devices
By Eric S. Langer, BioPlan Associates, Inc.
Published March 7, 2012
CMOs are spending twice as much as bio-innovators on single-use devices Read More »
By Steve Snyder, Contributing Editor
Published March 7, 2012
Positive signs for CROs Read More »
IT Focus: The Great Mediator
By Rolf Blumenthal, Werum Software & Systems AG
Published March 7, 2012
How MES can optimize the pharma supply chain Read More »
Manufacturing Equipment Trends
By Kristin Brooks, Associate Editor
Published March 7, 2012
Industry perspective from suppliers and manufacturers Read More »
Published February 29, 2012
McGrath and Phillips to head QC at Burlington site Read More »
By Gil Roth
Published February 28, 2012
Aptiv to add early phase trial design software to late phase offerings Read More »
Published February 27, 2012
A biotechnologically produced substance such as proteins, nucleic acids and other naturally occurring compounds derived from living cells for pharmaceutical applications.… Read More »
Published February 27, 2012
Will integrate TrueSpike into viral clearance services Read More »
Published February 24, 2012
Will expand clinical development in Russia Read More »
Published February 15, 2012
Mintzmyer to oversee expansion of commercial manufacturing operations Read More »
Published February 13, 2012
Services aim to help biopharma companies navigate the Asian market Read More »
Published February 9, 2012
Will lead the medical and regulatory service groups Read More »
Published February 7, 2012
Silva to focus on corporate strategy, acquisitions, outlicensing Read More »
Published February 3, 2012
To provide formulation development and manufacturing services Read More »
Published February 3, 2012
Appoints four industry experts Read More »
Published February 3, 2012
Will initially produce clinical batches for eight clinical trial sites Read More »
By Ed Silverman
Published January 23, 2012
No plan for Plan B? Read More »
By Steve Snyder
Published January 23, 2012
The realities of preclinical drug development Read More »
By E. Morrey Atkinson, Ph.D.
Published January 23, 2012
Both Sides of the Table Read More »
Trends and Novel Approaches to Clinical Supply Outsourcing
By Mary Jo Lamberti, Ph.D., Mary Costello, BA and Kenneth Getz, MBA
Published January 23, 2012
How are sponsor/provider relationships changing? Read More »
Published January 18, 2012
Will have strategic partnership with Quintiles Consulting and Quintiles Global Laboratories Read More »
By Gil Roth
Published January 17, 2012
Will work on DNA minor groove binder Read More »
By Gil Roth
Published January 10, 2012
Fifth biopharma alliance for Foundation Medicine Read More »
Published January 4, 2012
Casebier assumes responsibility for strategic R&D programs Read More »
By Gil Roth
Published December 19, 2011
Realtime analytical systems to complement microbiology offerings. Read More »
By Gil Roth
Published December 15, 2011
Moves HQ to NJ, boosts R&D in MA Read More »
By Lee Karras
Published December 14, 2011
Acquired by PE firms, the CRO looks to the future Read More »
By Gil Roth
Published December 13, 2011
Plans to double staff in China in 2012 Read More »
Published December 9, 2011
Aphale responsible for all internal and outsourced manufacturing Read More »
Published December 7, 2011
Expands Gyros platform in the Asia-Pacific region Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On